APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oligonucleotide Purification Media

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Oligonucleotide Purification Media Market Outlook and Growth Opportunities 2026

13 August 2026191 pages

Choose your research edition.

Industry ResearchOligonucleotide Purification Media Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Oligonucleotide Purification Media Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Oligonucleotide Purification Media Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oligonucleotide Purification Media Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Oligonucleotide Purification Media Market Analysis and Forecast 2026-2032212 pages · $4,950 USD

Market perspective

The global Oligonucleotide Purification Media market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Oligonucleotide Purification Media is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Oligonucleotide Purification Media is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oligonucleotide Purification Media is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Oligonucleotide Purification Media market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Oligonucleotide Purification Media market include Bio-Works, YMC, Tosoh Bioscience, Agilent, Thermo Fisher Scientific, Waters, NanoMicro, Bestchrom and Smart Lifesciences, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Oligonucleotide Purification Media market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Oligonucleotide Purification Media and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Oligonucleotide Purification Media sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Oligonucleotide Purification Media market size, projected growth trends, production technologies, key applications, and end-use industries.

Oligonucleotide Purification Media Segment by Company

Bio-Works

YMC

Tosoh Bioscience

Agilent

Thermo Fisher Scientific

Waters

NanoMicro

Bestchrom

Smart Lifesciences

Cytiva

DuPont

Bio-Rad

Oligonucleotide Purification Media Segment by Type

Strong Anion Exchange Media

Weak Anion Exchange Media

Reversed-Phase Media

Hydrophobic Interaction Media

Mixed-Mode Media

Size Exclusion Media

Oligonucleotide Purification Media Segment by Application

Therapeutic Oligonucleotide Manufacturing

Diagnostic and Research Oligo Purification

Process Development and Scale-Up

Impurity Removal and Polishing

Desalting and Buffer Exchange

Quality Control and Analytical Fractionation

Oligonucleotide Purification Media Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Oligonucleotide Purification Media status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Oligonucleotide Purification Media market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Oligonucleotide Purification Media significant trends, drivers, influence factors in global and regions.

6. To analyze Oligonucleotide Purification Media competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oligonucleotide Purification Media market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oligonucleotide Purification Media and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oligonucleotide Purification Media.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Oligonucleotide Purification Media market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Oligonucleotide Purification Media industry.

Chapter 3: Detailed analysis of Oligonucleotide Purification Media manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Oligonucleotide Purification Media in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Oligonucleotide Purification Media in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Oligonucleotide Purification Media Industry Trends Table 2. Oligonucleotide Purification Media Industry Drivers Table 3. Oligonucleotide Purification Media Industry Opportunities and Challenges Table 4. Oligonucleotide Purification Media Industry Restraints Table 5. Global Oligonucleotide Purification Media Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Oligonucleotide Purification Media Revenue Share by Company (2021-2026) Table 7. Global Oligonucleotide Purification Media Sales Volume by Company (t) & (2021-2026) Table 8. Global Oligonucleotide Purification Media Sales Volume Share by Company (2021-2026) Table 9. Global Oligonucleotide Purification Media Average Price (USD/t) of Company (2021-2026) Table 10. Global Oligonucleotide Purification Media Company Ranking, (2024-2026) & (USD Million) Table 11. Global Oligonucleotide Purification Media Key Company Manufacturing Base & Headquarters Table 12. Global Oligonucleotide Purification Media Company, Product Type & Application Table 13. Global Oligonucleotide Purification Media Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Oligonucleotide Purification Media by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Strong Anion Exchange Media Table 18. Significant Companies of Weak Anion Exchange Media Table 19. Significant Companies of Reversed-Phase Media Table 20. Significant Companies of Hydrophobic Interaction Media Table 21. Significant Companies of Mixed-Mode Media Table 22. Significant Companies of Size Exclusion Media Table 23. Global Oligonucleotide Purification Media Sales Volume by Type 2021 VS 2025 VS 2032 (t) Table 24. Global Oligonucleotide Purification Media Sales Volume by Type (2021-2026) & (t) Table 25. Global Oligonucleotide Purification Media Sales Volume by Type (2027-2032) & (t) Table 26. Global Oligonucleotide Purification Media Sales Volume Share by Type (2021-2026) Table 27. Global Oligonucleotide Purification Media Sales Volume Share by Type (2027-2032) Table 28. Global Oligonucleotide Purification Media Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Oligonucleotide Purification Media Sales Value by Type (2021-2026) & (US$ Million) Table 30. Global Oligonucleotide Purification Media Sales Value by Type (2027-2032) & (US$ Million) Table 31. Global Oligonucleotide Purification Media Sales Value Share by Type (2021-2026) Table 32. Global Oligonucleotide Purification Media Sales Value Share by Type (2027-2032) Table 33. Significant Companies of Therapeutic Oligonucleotide Manufacturing Table 34. Significant Companies of Diagnostic and Research Oligo Purification Table 35. Significant Companies of Process Development and Scale-Up Table 36. Significant Companies of Impurity Removal and Polishing Table 37. Significant Companies of Desalting and Buffer Exchange Table 38. Significant Companies of Quality Control and Analytical Fractionation Table 39. Global Oligonucleotide Purification Media Sales Volume by Application 2021 VS 2025 VS 2032 (t) Table 40. Global Oligonucleotide Purification Media Sales Volume by Application (2021-2026) & (t) Table 41. Global Oligonucleotide Purification Media Sales Volume by Application (2027-2032) & (t) Table 42. Global Oligonucleotide Purification Media Sales Volume Share by Application (2021-2026) Table 43. Global Oligonucleotide Purification Media Sales Volume Share by Application (2027-2032) Table 44. Global Oligonucleotide Purification Media Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Oligonucleotide Purification Media Sales Value by Application (2021-2026) & (US$ Million) Table 46. Global Oligonucleotide Purification Media Sales Value by Application (2027-2032) & (US$ Million) Table 47. Global Oligonucleotide Purification Media Sales Value Share by Application (2021-2026) Table 48. Global Oligonucleotide Purification Media Sales Value Share by Application (2027-2032) Table 49. Global Oligonucleotide Purification Media Sales by Region: 2021 VS 2025 VS 2032 (t) Table 50. Global Oligonucleotide Purification Media Sales by Region (2021-2026) & (t) Table 51. Global Oligonucleotide Purification Media Sales Market Share by Region (2021-2026) Table 52. Global Oligonucleotide Purification Media Sales by Region (2027-2032) & (t) Table 53. Global Oligonucleotide Purification Media Sales Market Share by Region (2027-2032) Table 54. Global Oligonucleotide Purification Media Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Oligonucleotide Purification Media Sales Value by Region (2021-2026) & (US$ Million) Table 56. Global Oligonucleotide Purification Media Sales Value Share by Region (2021-2026) Table 57. Global Oligonucleotide Purification Media Sales Value by Region (2027-2032) & (US$ Million) Table 58. Global Oligonucleotide Purification Media Sales Value Share by Region (2027-2032) Table 59. Global Oligonucleotide Purification Media Market Average Price (USD/t) by Region (2021-2026) Table 60. Global Oligonucleotide Purification Media Market Average Price (USD/t) by Region (2027-2032) Table 61. Global Oligonucleotide Purification Media Sales by Country: 2021 VS 2025 VS 2032 (t) Table 62. Global Oligonucleotide Purification Media Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global Oligonucleotide Purification Media Sales by Country (2021-2026) & (t) Table 64. Global Oligonucleotide Purification Media Sales Market Share by Country (2021-2026) Table 65. Global Oligonucleotide Purification Media Sales by Country (2027-2032) & (t) Table 66. Global Oligonucleotide Purification Media Sales Market Share by Country (2027-2032) Table 67. Global Oligonucleotide Purification Media Sales Value by Country (2021-2026) & (US$ Million) Table 68. Global Oligonucleotide Purification Media Sales Value Market Share by Country (2021-2026) Table 69. Global Oligonucleotide Purification Media Sales Value by Country (2027-2032) & (US$ Million) Table 70. Global Oligonucleotide Purification Media Sales Value Market Share by Country (2027-2032) Table 71. Bio-Works Company Information Table 72. Bio-Works Business Overview Table 73. Bio-Works Oligonucleotide Purification Media Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 74. Bio-Works Oligonucleotide Purification Media Product Portfolio Table 75. Bio-Works Recent Development Table 76. YMC Company Information Table 77. YMC Business Overview Table 78. YMC Oligonucleotide Purification Media Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 79. YMC Oligonucleotide Purification Media Product Portfolio Table 80. YMC Recent Development Table 81. Tosoh Bioscience Company Information Table 82. Tosoh Bioscience Business Overview Table 83. Tosoh Bioscience Oligonucleotide Purification Media Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 84. Tosoh Bioscience Oligonucleotide Purification Media Product Portfolio Table 85. Tosoh Bioscience Recent Development Table 86. Agilent Company Information Table 87. Agilent Business Overview Table 88. Agilent Oligonucleotide Purification Media Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 89. Agilent Oligonucleotide Purification Media Product Portfolio Table 90. Agilent Recent Development Table 91. Thermo Fisher Scientific Company Information Table 92. Thermo Fisher Scientific Business Overview Table 93. Thermo Fisher Scientific Oligonucleotide Purification Media Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 94. Thermo Fisher Scientific Oligonucleotide Purification Media Product Portfolio Table 95. Thermo Fisher Scientific Recent Development Table 96. Waters Company Information Table 97. Waters Business Overview Table 98. Waters Oligonucleotide Purification Media Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 99. Waters Oligonucleotide Purification Media Product Portfolio Table 100. Waters Recent Development Table 101. NanoMicro Company Information Table 102. NanoMicro Business Overview Table 103. NanoMicro Oligonucleotide Purification Media Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 104. NanoMicro Oligonucleotide Purification Media Product Portfolio Table 105. NanoMicro Recent Development Table 106. Bestchrom Company Information Table 107. Bestchrom Business Overview Table 108. Bestchrom Oligonucleotide Purification Media Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 109. Bestchrom Oligonucleotide Purification Media Product Portfolio Table 110. Bestchrom Recent Development Table 111. Smart Lifesciences Company Information Table 112. Smart Lifesciences Business Overview Table 113. Smart Lifesciences Oligonucleotide Purification Media Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 114. Smart Lifesciences Oligonucleotide Purification Media Product Portfolio Table 115. Smart Lifesciences Recent Development Table 116. Cytiva Company Information Table 117. Cytiva Business Overview Table 118. Cytiva Oligonucleotide Purification Media Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 119. Cytiva Oligonucleotide Purification Media Product Portfolio Table 120. Cytiva Recent Development Table 121. DuPont Company Information Table 122. DuPont Business Overview Table 123. DuPont Oligonucleotide Purification Media Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 124. DuPont Oligonucleotide Purification Media Product Portfolio Table 125. DuPont Recent Development Table 126. Bio-Rad Company Information Table 127. Bio-Rad Business Overview Table 128. Bio-Rad Oligonucleotide Purification Media Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 129. Bio-Rad Oligonucleotide Purification Media Product Portfolio Table 130. Bio-Rad Recent Development Table 131. Key Raw Materials Table 132. Raw Materials Key Suppliers Table 133. Oligonucleotide Purification Media Distributors List Table 134. Oligonucleotide Purification Media Customers List Table 135. Research Programs/Design for This Report Table 136. Authors List of This Report Table 137. Secondary Sources Table 138. Primary Sources List of Figures Figure 1. Oligonucleotide Purification Media Product Image Figure 2. Global Oligonucleotide Purification Media Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oligonucleotide Purification Media Sales Value (2021-2032) & (US$ Million) Figure 4. Global Oligonucleotide Purification Media Sales (2021-2032) & (t) Figure 5. Global Oligonucleotide Purification Media Sales Average Price (USD/t) & (2021-2032) Figure 6. Global Oligonucleotide Purification Media Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Strong Anion Exchange Media Image Figure 10. Weak Anion Exchange Media Image Figure 11. Reversed-Phase Media Image Figure 12. Hydrophobic Interaction Media Image Figure 13. Mixed-Mode Media Image Figure 14. Size Exclusion Media Image Figure 15. Global Oligonucleotide Purification Media Sales Volume by Type (2021 VS 2025 VS 2032) & (t) Figure 16. Global Oligonucleotide Purification Media Sales Volume Share 2021 VS 2025 VS 2032 Figure 17. Global Oligonucleotide Purification Media Sales Volume Share by Type (2021-2032) Figure 18. Global Oligonucleotide Purification Media Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Oligonucleotide Purification Media Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Oligonucleotide Purification Media Sales Value Share by Type (2021-2032) Figure 21. Therapeutic Oligonucleotide Manufacturing Image Figure 22. Diagnostic and Research Oligo Purification Image Figure 23. Process Development and Scale-Up Image Figure 24. Impurity Removal and Polishing Image Figure 25. Desalting and Buffer Exchange Image Figure 26. Quality Control and Analytical Fractionation Image Figure 27. Global Oligonucleotide Purification Media Sales Volume by Application (2021 VS 2025 VS 2032) & (t) Figure 28. Global Oligonucleotide Purification Media Sales Volume Share 2021 VS 2025 VS 2032 Figure 29. Global Oligonucleotide Purification Media Sales Volume Share by Application (2021-2032) Figure 30. Global Oligonucleotide Purification Media Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Oligonucleotide Purification Media Sales Value Share 2021 VS 2025 VS 2032 Figure 32. Global Oligonucleotide Purification Media Sales Value Share by Application (2021-2032) Figure 33. Global Oligonucleotide Purification Media Sales by Region: 2021 VS 2025 VS 2032 (t) Figure 34. Global Oligonucleotide Purification Media Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 35. Global Oligonucleotide Purification Media Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 36. Global Oligonucleotide Purification Media Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 37. North America Oligonucleotide Purification Media Sales Value (2021-2032) & (US$ Million) Figure 38. North America Oligonucleotide Purification Media Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Europe Oligonucleotide Purification Media Sales Value (2021-2032) & (US$ Million) Figure 40. Europe Oligonucleotide Purification Media Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Asia-Pacific Oligonucleotide Purification Media Sales Value (2021-2032) & (US$ Million) Figure 42. Asia-Pacific Oligonucleotide Purification Media Sales Value Share by Country (%), 2025 VS 2032 Figure 43. South America Oligonucleotide Purification Media Sales Value (2021-2032) & (US$ Million) Figure 44. South America Oligonucleotide Purification Media Sales Value Share by Country (%), 2025 VS 2032 Figure 45. Middle East & Africa Oligonucleotide Purification Media Sales Value (2021-2032) & (US$ Million) Figure 46. Middle East & Africa Oligonucleotide Purification Media Sales Value Share by Country (%), 2025 VS 2032 Figure 47. USA Oligonucleotide Purification Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. USA Oligonucleotide Purification Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. USA Oligonucleotide Purification Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Canada Oligonucleotide Purification Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Canada Oligonucleotide Purification Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Canada Oligonucleotide Purification Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Mexico Oligonucleotide Purification Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Mexico Oligonucleotide Purification Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Mexico Oligonucleotide Purification Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Germany Oligonucleotide Purification Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Germany Oligonucleotide Purification Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Germany Oligonucleotide Purification Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. France Oligonucleotide Purification Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. France Oligonucleotide Purification Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. France Oligonucleotide Purification Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. U.K. Oligonucleotide Purification Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. U.K. Oligonucleotide Purification Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. U.K. Oligonucleotide Purification Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Italy Oligonucleotide Purification Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Italy Oligonucleotide Purification Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Italy Oligonucleotide Purification Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Spain Oligonucleotide Purification Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Spain Oligonucleotide Purification Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Spain Oligonucleotide Purification Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Russia Oligonucleotide Purification Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Russia Oligonucleotide Purification Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Russia Oligonucleotide Purification Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Netherlands Oligonucleotide Purification Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Netherlands Oligonucleotide Purification Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Netherlands Oligonucleotide Purification Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Nordic Countries Oligonucleotide Purification Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Nordic Countries Oligonucleotide Purification Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Nordic Countries Oligonucleotide Purification Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. China Oligonucleotide Purification Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. China Oligonucleotide Purification Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. China Oligonucleotide Purification Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Japan Oligonucleotide Purification Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Japan Oligonucleotide Purification Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Japan Oligonucleotide Purification Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. South Korea Oligonucleotide Purification Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. South Korea Oligonucleotide Purification Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. South Korea Oligonucleotide Purification Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. India Oligonucleotide Purification Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. India Oligonucleotide Purification Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. India Oligonucleotide Purification Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Australia Oligonucleotide Purification Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Australia Oligonucleotide Purification Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Australia Oligonucleotide Purification Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Southeast Asia Oligonucleotide Purification Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Southeast Asia Oligonucleotide Purification Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Southeast Asia Oligonucleotide Purification Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Brazil Oligonucleotide Purification Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Brazil Oligonucleotide Purification Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Brazil Oligonucleotide Purification Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Argentina Oligonucleotide Purification Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Argentina Oligonucleotide Purification Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Argentina Oligonucleotide Purification Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Chile Oligonucleotide Purification Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Chile Oligonucleotide Purification Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Chile Oligonucleotide Purification Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Colombia Oligonucleotide Purification Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Colombia Oligonucleotide Purification Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Colombia Oligonucleotide Purification Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Peru Oligonucleotide Purification Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Peru Oligonucleotide Purification Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Peru Oligonucleotide Purification Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Saudi Arabia Oligonucleotide Purification Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Saudi Arabia Oligonucleotide Purification Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Saudi Arabia Oligonucleotide Purification Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Israel Oligonucleotide Purification Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Israel Arabia Oligonucleotide Purification Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Israel Arabia Oligonucleotide Purification Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. UAE Oligonucleotide Purification Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. UAE Oligonucleotide Purification Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. UAE Oligonucleotide Purification Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Turkey Oligonucleotide Purification Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Turkey Oligonucleotide Purification Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Turkey Oligonucleotide Purification Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Iran Oligonucleotide Purification Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 126. Iran Oligonucleotide Purification Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 127. Iran Oligonucleotide Purification Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 128. Egypt Oligonucleotide Purification Media Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 129. Egypt Oligonucleotide Purification Media Sales Value Share by Type, 2025 VS 2032 & (%) Figure 130. Egypt Oligonucleotide Purification Media Sales Value Share by Application, 2025 VS 2032 & (%) Figure 131. Oligonucleotide Purification Media Value Chain Figure 132. Manufacturing Cost Structure Figure 133. Oligonucleotide Purification Media Sales Mode & Process Figure 134. Direct Comparison with Distribution Share Figure 135. Distributors Profiles Figure 136. Years Considered Figure 137. Research Process Figure 138. Key Executives Interviewed

Scope & coverage.

Types
  • Strong Anion Exchange Media
  • Weak Anion Exchange Media
  • Reversed-Phase Media
  • Hydrophobic Interaction Media
  • Mixed-Mode Media
  • Size Exclusion Media
Applications
  • Therapeutic Oligonucleotide Manufacturing
  • Diagnostic and Research Oligo Purification
  • Process Development and Scale-Up
  • Impurity Removal and Polishing
  • Desalting and Buffer Exchange
  • Quality Control and Analytical Fractionation
Companies covered
  • Bio-Works
  • YMC
  • Tosoh Bioscience
  • Agilent
  • Thermo Fisher Scientific
  • Waters
  • NanoMicro
  • Bestchrom
  • Smart Lifesciences
  • Cytiva
  • DuPont
  • Bio-Rad

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Oligonucleotide Purification Media Sales Value (2021-2032)
  4. 1.2.2 Global Oligonucleotide Purification Media Sales Volume (2021-2032)
  5. 1.2.3 Global Oligonucleotide Purification Media Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Oligonucleotide Purification Media Market Dynamics
  1. 2.1 Oligonucleotide Purification Media Industry Trends
  2. 2.2 Oligonucleotide Purification Media Industry Drivers
  3. 2.3 Oligonucleotide Purification Media Industry Opportunities and Challenges
  4. 2.4 Oligonucleotide Purification Media Industry Restraints
3 Oligonucleotide Purification Media Market by Company
  1. 3.1 Global Oligonucleotide Purification Media Company Revenue Ranking in 2025
  2. 3.2 Global Oligonucleotide Purification Media Revenue by Company (2021-2026)
  3. 3.3 Global Oligonucleotide Purification Media Sales Volume by Company (2021-2026)
  4. 3.4 Global Oligonucleotide Purification Media Average Price by Company (2021-2026)
  5. 3.5 Global Oligonucleotide Purification Media Company Ranking (2024-2026)
  6. 3.6 Global Oligonucleotide Purification Media Company Manufacturing Base and Headquarters
  7. 3.7 Global Oligonucleotide Purification Media Company Product Type and Application
  8. 3.8 Global Oligonucleotide Purification Media Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Oligonucleotide Purification Media Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Oligonucleotide Purification Media Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Oligonucleotide Purification Media Market by Type
  1. 4.1 Oligonucleotide Purification Media Type Introduction
  2. 4.1.1 Strong Anion Exchange Media
  3. 4.1.2 Weak Anion Exchange Media
  4. 4.1.3 Reversed-Phase Media
  5. 4.1.4 Hydrophobic Interaction Media
  6. 4.1.5 Mixed-Mode Media
  7. 4.1.6 Size Exclusion Media
  8. 4.2 Global Oligonucleotide Purification Media Sales Volume by Type
  9. 4.2.1 Global Oligonucleotide Purification Media Sales Volume by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Oligonucleotide Purification Media Sales Volume by Type (2021-2032)
  11. 4.2.3 Global Oligonucleotide Purification Media Sales Volume Share by Type (2021-2032)
  12. 4.3 Global Oligonucleotide Purification Media Sales Value by Type
  13. 4.3.1 Global Oligonucleotide Purification Media Sales Value by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Oligonucleotide Purification Media Sales Value by Type (2021-2032)
  15. 4.3.3 Global Oligonucleotide Purification Media Sales Value Share by Type (2021-2032)
5 Oligonucleotide Purification Media Market by Application
  1. 5.1 Oligonucleotide Purification Media Application Introduction
  2. 5.1.1 Therapeutic Oligonucleotide Manufacturing
  3. 5.1.2 Diagnostic and Research Oligo Purification
  4. 5.1.3 Process Development and Scale-Up
  5. 5.1.4 Impurity Removal and Polishing
  6. 5.1.5 Desalting and Buffer Exchange
  7. 5.1.6 Quality Control and Analytical Fractionation
  8. 5.2 Global Oligonucleotide Purification Media Sales Volume by Application
  9. 5.2.1 Global Oligonucleotide Purification Media Sales Volume by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global Oligonucleotide Purification Media Sales Volume by Application (2021-2032)
  11. 5.2.3 Global Oligonucleotide Purification Media Sales Volume Share by Application (2021-2032)
  12. 5.3 Global Oligonucleotide Purification Media Sales Value by Application
  13. 5.3.1 Global Oligonucleotide Purification Media Sales Value by Application (2021 VS 2025 VS 2032)
  14. 5.3.2 Global Oligonucleotide Purification Media Sales Value by Application (2021-2032)
  15. 5.3.3 Global Oligonucleotide Purification Media Sales Value Share by Application (2021-2032)
6 Oligonucleotide Purification Media Regional Sales and Value Analysis
  1. 6.1 Global Oligonucleotide Purification Media Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Oligonucleotide Purification Media Sales by Region (2021-2032)
  3. 6.2.1 Global Oligonucleotide Purification Media Sales by Region: 2021-2026
  4. 6.2.2 Global Oligonucleotide Purification Media Sales by Region (2027-2032)
  5. 6.3 Global Oligonucleotide Purification Media Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Oligonucleotide Purification Media Sales Value by Region (2021-2032)
  7. 6.4.1 Global Oligonucleotide Purification Media Sales Value by Region: 2021-2026
  8. 6.4.2 Global Oligonucleotide Purification Media Sales Value by Region (2027-2032)
  9. 6.5 Global Oligonucleotide Purification Media Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Oligonucleotide Purification Media Sales Value (2021-2032)
  12. 6.6.2 North America Oligonucleotide Purification Media Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Oligonucleotide Purification Media Sales Value (2021-2032)
  15. 6.7.2 Europe Oligonucleotide Purification Media Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Oligonucleotide Purification Media Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Oligonucleotide Purification Media Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Oligonucleotide Purification Media Sales Value (2021-2032)
  21. 6.9.2 South America Oligonucleotide Purification Media Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Oligonucleotide Purification Media Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Oligonucleotide Purification Media Sales Value Share by Country, 2025 VS 2032
7 Oligonucleotide Purification Media Country-level Sales and Value Analysis
  1. 7.1 Global Oligonucleotide Purification Media Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Oligonucleotide Purification Media Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Oligonucleotide Purification Media Sales by Country (2021-2032)
  4. 7.3.1 Global Oligonucleotide Purification Media Sales by Country (2021-2026)
  5. 7.3.2 Global Oligonucleotide Purification Media Sales by Country (2027-2032)
  6. 7.4 Global Oligonucleotide Purification Media Sales Value by Country (2021-2032)
  7. 7.4.1 Global Oligonucleotide Purification Media Sales Value by Country (2021-2026)
  8. 7.4.2 Global Oligonucleotide Purification Media Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Oligonucleotide Purification Media Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Oligonucleotide Purification Media Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Oligonucleotide Purification Media Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Oligonucleotide Purification Media Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Oligonucleotide Purification Media Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Oligonucleotide Purification Media Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Oligonucleotide Purification Media Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Oligonucleotide Purification Media Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Oligonucleotide Purification Media Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Oligonucleotide Purification Media Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Oligonucleotide Purification Media Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Oligonucleotide Purification Media Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Oligonucleotide Purification Media Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Oligonucleotide Purification Media Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Oligonucleotide Purification Media Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Oligonucleotide Purification Media Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Oligonucleotide Purification Media Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Oligonucleotide Purification Media Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Oligonucleotide Purification Media Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Oligonucleotide Purification Media Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Oligonucleotide Purification Media Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Oligonucleotide Purification Media Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Oligonucleotide Purification Media Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Oligonucleotide Purification Media Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Oligonucleotide Purification Media Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Oligonucleotide Purification Media Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Oligonucleotide Purification Media Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Oligonucleotide Purification Media Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Oligonucleotide Purification Media Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Oligonucleotide Purification Media Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Oligonucleotide Purification Media Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Oligonucleotide Purification Media Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Oligonucleotide Purification Media Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Oligonucleotide Purification Media Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Oligonucleotide Purification Media Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Oligonucleotide Purification Media Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Oligonucleotide Purification Media Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Oligonucleotide Purification Media Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Oligonucleotide Purification Media Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Oligonucleotide Purification Media Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Oligonucleotide Purification Media Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Oligonucleotide Purification Media Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Oligonucleotide Purification Media Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Oligonucleotide Purification Media Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Oligonucleotide Purification Media Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Oligonucleotide Purification Media Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Oligonucleotide Purification Media Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Oligonucleotide Purification Media Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Oligonucleotide Purification Media Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Oligonucleotide Purification Media Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Oligonucleotide Purification Media Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Oligonucleotide Purification Media Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Oligonucleotide Purification Media Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Oligonucleotide Purification Media Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Oligonucleotide Purification Media Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Oligonucleotide Purification Media Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Oligonucleotide Purification Media Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Oligonucleotide Purification Media Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Oligonucleotide Purification Media Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Oligonucleotide Purification Media Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Oligonucleotide Purification Media Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Oligonucleotide Purification Media Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Oligonucleotide Purification Media Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Oligonucleotide Purification Media Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Oligonucleotide Purification Media Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Oligonucleotide Purification Media Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Oligonucleotide Purification Media Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Oligonucleotide Purification Media Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Oligonucleotide Purification Media Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Oligonucleotide Purification Media Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Oligonucleotide Purification Media Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Oligonucleotide Purification Media Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Oligonucleotide Purification Media Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Oligonucleotide Purification Media Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Oligonucleotide Purification Media Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Oligonucleotide Purification Media Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Oligonucleotide Purification Media Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Oligonucleotide Purification Media Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Oligonucleotide Purification Media Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Oligonucleotide Purification Media Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Oligonucleotide Purification Media Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Oligonucleotide Purification Media Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Oligonucleotide Purification Media Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Oligonucleotide Purification Media Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Bio-Works
  2. 8.1.1 Bio-Works Company Information
  3. 8.1.2 Bio-Works Business Overview
  4. 8.1.3 Bio-Works Oligonucleotide Purification Media Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Bio-Works Oligonucleotide Purification Media Product Portfolio
  6. 8.1.5 Bio-Works Recent Developments
  7. 8.2 YMC
  8. 8.2.1 YMC Company Information
  9. 8.2.2 YMC Business Overview
  10. 8.2.3 YMC Oligonucleotide Purification Media Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 YMC Oligonucleotide Purification Media Product Portfolio
  12. 8.2.5 YMC Recent Developments
  13. 8.3 Tosoh Bioscience
  14. 8.3.1 Tosoh Bioscience Company Information
  15. 8.3.2 Tosoh Bioscience Business Overview
  16. 8.3.3 Tosoh Bioscience Oligonucleotide Purification Media Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Tosoh Bioscience Oligonucleotide Purification Media Product Portfolio
  18. 8.3.5 Tosoh Bioscience Recent Developments
  19. 8.4 Agilent
  20. 8.4.1 Agilent Company Information
  21. 8.4.2 Agilent Business Overview
  22. 8.4.3 Agilent Oligonucleotide Purification Media Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Agilent Oligonucleotide Purification Media Product Portfolio
  24. 8.4.5 Agilent Recent Developments
  25. 8.5 Thermo Fisher Scientific
  26. 8.5.1 Thermo Fisher Scientific Company Information
  27. 8.5.2 Thermo Fisher Scientific Business Overview
  28. 8.5.3 Thermo Fisher Scientific Oligonucleotide Purification Media Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Thermo Fisher Scientific Oligonucleotide Purification Media Product Portfolio
  30. 8.5.5 Thermo Fisher Scientific Recent Developments
  31. 8.6 Waters
  32. 8.6.1 Waters Company Information
  33. 8.6.2 Waters Business Overview
  34. 8.6.3 Waters Oligonucleotide Purification Media Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Waters Oligonucleotide Purification Media Product Portfolio
  36. 8.6.5 Waters Recent Developments
  37. 8.7 NanoMicro
  38. 8.7.1 NanoMicro Company Information
  39. 8.7.2 NanoMicro Business Overview
  40. 8.7.3 NanoMicro Oligonucleotide Purification Media Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 NanoMicro Oligonucleotide Purification Media Product Portfolio
  42. 8.7.5 NanoMicro Recent Developments
  43. 8.8 Bestchrom
  44. 8.8.1 Bestchrom Company Information
  45. 8.8.2 Bestchrom Business Overview
  46. 8.8.3 Bestchrom Oligonucleotide Purification Media Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Bestchrom Oligonucleotide Purification Media Product Portfolio
  48. 8.8.5 Bestchrom Recent Developments
  49. 8.9 Smart Lifesciences
  50. 8.9.1 Smart Lifesciences Company Information
  51. 8.9.2 Smart Lifesciences Business Overview
  52. 8.9.3 Smart Lifesciences Oligonucleotide Purification Media Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Smart Lifesciences Oligonucleotide Purification Media Product Portfolio
  54. 8.9.5 Smart Lifesciences Recent Developments
  55. 8.10 Cytiva
  56. 8.10.1 Cytiva Company Information
  57. 8.10.2 Cytiva Business Overview
  58. 8.10.3 Cytiva Oligonucleotide Purification Media Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Cytiva Oligonucleotide Purification Media Product Portfolio
  60. 8.10.5 Cytiva Recent Developments
  61. 8.11 DuPont
  62. 8.11.1 DuPont Company Information
  63. 8.11.2 DuPont Business Overview
  64. 8.11.3 DuPont Oligonucleotide Purification Media Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 DuPont Oligonucleotide Purification Media Product Portfolio
  66. 8.11.5 DuPont Recent Developments
  67. 8.12 Bio-Rad
  68. 8.12.1 Bio-Rad Company Information
  69. 8.12.2 Bio-Rad Business Overview
  70. 8.12.3 Bio-Rad Oligonucleotide Purification Media Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Bio-Rad Oligonucleotide Purification Media Product Portfolio
  72. 8.12.5 Bio-Rad Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Oligonucleotide Purification Media Value Chain Analysis
  2. 9.1.1 Oligonucleotide Purification Media Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Oligonucleotide Purification Media Sales Mode & Process
  6. 9.2 Oligonucleotide Purification Media Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Oligonucleotide Purification Media Distributors
  9. 9.2.3 Oligonucleotide Purification Media Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst